Intelligence Matrix
Divergent Perspectives
Every angle at once: who benefits, who gets squeezed, and how the story lands for the public, the state, elites, and class tiers from a U.S.-first lens.
Generating America-first perspectives...
RT by NYT: The Trump Administration's decision to ban a synthetic version of kratom has created a lucrative opportunity for makers of rival botanic supplements, who had lobbied for the change, highlighting the complex interplay between regulatory actions and market outcomes in the supplement industry.
Looking for the best next stories...
Share the findings or join the discussion.
No comments yet. Start the conversation.